Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

BACKGROUND: While programmed death 1 (PD-1) and programmed death-ligand 1 (PD-L1) checkpoint inhibitors have activity in a proportion of patients with advanced bladder cancer, strongly predictive and prognostic biomarkers are still lacking. In this study, we evaluated PD-L1 protein expression on cir...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Anantharaman, Archana, Friedlander, Terence, Lu, David, Krupa, Rachel, Premasekharan, Gayatri, Hough, Jeffrey, Edwards, Matthew, Paz, Rosa, Lindquist, Karla, Graf, Ryon, Jendrisak, Adam, Louw, Jessica, Dugan, Lyndsey, Baird, Sarah, Wang, Yipeng, Dittamore, Ryan, Paris, Pamela L.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034508/
https://ncbi.nlm.nih.gov/pubmed/27658492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2758-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados